8-K
Current Report
Axsome Therapeutics, Inc. Filed Acc 0001104659-18-024992
Executive or director change · Regulation FD disclosure
- Item 5.02 Departure or appointment of directors or officers
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading a18-11193_18k.htm…